Search

Methoxyamine

Azelnidipine

It is marketed by Daiichi-Sankyo pharmaceuticals, Inc. in Japan.

N-(2-Aminoethyl)-1-aziridineethanamine

First described in the literature in 2004, N-(2-Aminoethyl)-1-aziridineethanamine is an experimental angiotensin converting enzyme 2 inhibitor investigated for its use in treating cardiovascular disease

TC-5231

TC-5231 is mecamylamine hydrochloride, the active ingredient in FDA-approved product, Inversine, but in a lower dose than Inversine. … TC-5231 is a small molecule that has been under investigation as an oral treatment for ADHD (Attention Deficit/Hyperactivity Disorder).

AUTO3

It is an investigational chimeric antigen receptor (CAR) T cell treatment targeting CD19 and CD22.

KITE-585

KITE-585 is an autologous, fully-human anti-B cell maturation antigen (BCMA) chimeric antigen receptor (CAR) T cell therapy. It is being investigated in the treatment of multiple myeloma.

Sparfosic acid

This substance is known to target aspartate carbamoyltransferase catalytic chain and CAD protein. … These are compounds containing an alpha amino acid which bears an acyl group at the terminal nitrogen atom.

Alvocidib

It works by inhibiting cyclin-dependent kinases, arresting cell division and causing apoptosis in non-small lung cancer cells. … Alvocidib is a synthetic flavonoid based on an extract from an Indian plant for the potential treatment of cancer.

Reversin 121

Reversin 121 is a hydrophobic peptide chemosensitizer that can reverse P-glycoprotein-mediated multidrug resistance.

Quinupramine

Quinupramine has been approved in France under the brand name Kinupril, as an antidepressant [A175003].